VE Neuroprotection - Annals of Internal Medicine, 2005 - Am Coll Physicians I n January 2005, we published a dose–response meta- analysis showing that high-dosage (
400 IU/d) vitamin E supplementation was associated with a small but statis- tically significant
increased risk for mortality (relative risk, 1.04 [95% CI, 1.01 to 1.07]) (1). The precise ... Related articles
- ►shouxi.net D Blacker - New England Journal of Medicine, 2005 - content.nejm.org In this issue of the Journal, Petersen et al. present the long-awaited results of a randomized,
placebo-controlled trial of donepezil, a standard therapy for Alzheimer's disease, and the widely
used antioxidant vitamin E as an early intervention for mild cognitive impairment — ... Cited by 24 - Related articles - All 8 versions
MJ Rack, S Rack - jfponline.com Treating moderate Alzheimer's disease (AD). Sano et al found little difference in effectiveness
between selegiline, 10 mg/d; vitamin E, 2,000 IU/d; concomitant selegiline and vitamin E; or
placebo. 4 After considering the placebo group's higher baseline Mini-Mental State ... Related articles - Cached
MW Dysken, LN Kirk, M Kuskowski - American Journal of Geriatric …, 2009 - journals.lww.com Objective: At the end of 2006, a survey was sent to members of the American Association of Geriatric
Psychiatry (AAGP) to assess possible changes in prescribing Vitamin E to patients with Alzheimer
disease that followed two published reports in early 2005 suggesting increased mortality ... Related articles - All 2 versions
BS Oken, S Doody… - Neurology, 2001 - AAN Enterprises The reviewers considered vitamin E a guideline but the single controlled trial 2 was much less
conclusive than the practice parameter suggests. The uncorrected, first-pass data analysis revealed
no significant (p < 0.05) beneficial effect of vitamin E. After correction for a slight baseline ... Cited by 1 - Related articles - BL Direct - All 3 versions
ER Miller III, E Guallar - Clinical Trials, 2009 - ctj.sagepub.com Oxidative modification of DNA and lipids is thought to be an important step in the pathogen- esis
of cancer, atherosclerosis, Alzheimer's disease and other chronic diseases. This biological
ratio- nale, combined with the results of observational studies, provided a strong ... Related articles - All 2 versions
